Skip to main content

Aggregator

Cotton Bouncing Back on Wednesday Morning

5 days 11 hours ago
Cotton prices are back up 34 to 48 points early on Wednesday. Futures closed the Tuesday session with contracts down 79 to 112 points across the board. Crude oil is down $1.56 per barrel on the session, with the US dollar index $0.410 higher. Crop Progress data tallied 89% of...

Stocks Mixed as FOMC Results Are Awaited

5 days 11 hours ago
The S&P 500 Index ($SPX ) (SPY ) is up +0.11%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.19%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.29%. December E-mini S&P futures (ESZ26 ) are down -0.02%, and December E-mini Nasdaq futures (NQZ26...

Stocks Little Changed After Divided Fed Holds Rates Steady

5 days 11 hours ago
The S&P 500 Index ($SPX ) (SPY ) is up +0.16%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.21%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.17%. December E-mini S&P futures (ESZ26 ) are up +0.06%, and December E-mini Nasdaq futures (NQZ26...

Chris Wright Says Diesel Exports From Arabian Gulf Likely to Increase

5 days 11 hours ago
Energy Secretary Chris Wright said that he expects diesel prices to be 'dropped significantly' but will need increased exports out of the Arabian Gulf to manage it amid the ongoing war with Iran. Wright also Russia's diesel output, saying that the only way Russia can benefit from recently permitted exports of diesel is to deliver a ceasefire on energy or end the war. (Source: Bloomberg)

Microsoft is ending Copilot support on smart TVs

5 days 11 hours ago
Nearly two years after LG and Samsung announced at CES 2025 that their latest smart TVs would include access to Microsoft's Copilot, the company is ending support for the AI assistant's functionality on all TVs this year, according to a report by Windows Central. The news comes not from an official announcement from LG, Samsung, […]

FDA scientists opposed Trump administration’s move to ease peptide access

5 days 11 hours ago

Effort to loosen rules on unproven peptide drugs, favored by RFK Jr, faced fierce pushback from agency scientists

A plan to give people in the United States easier access to unproven peptide drugs favored by the US health secretary, Robert F Kennedy Jr, was opposed by most Food and Drug Administration scientific staff members, who had limited input in drafting the policy, according to six people familiar with its development.

The document posted online on Wednesday by Kennedy’s Department of Health and Human Services (HHS) covers a handful of injectable peptides promoted within the wellness industry for building muscle, healing injuries and boosting energy.

Continue reading...